When Indian stand-up comedian and content creator Aishwarya Mohanraj dropped a candid YouTube video in February 2026 detailing her six-month transformation, the internet stopped scrolling. She had lost 22 kilograms — going from 74 kg down to 52 kg — using a weekly injectable prescription drug called Mounjaro (tirzepatide). The video racked up millions of views within days, and search queries around Aishwarya Mohanraj Mounjaro weight loss exploded across India and beyond.
Disclaimer:This article is for informational purposes only and does not constitute medical advice. Mounjaro (tirzepatide) is a prescription medication. Always consult a qualified healthcare professional before starting any medication or weight loss program.
Who Is Aishwarya Mohanraj?
Aishwarya Mohanraj is a Chennai-based Indian stand-up comedian and digital content creator known for her sharp, relatable comedy. She has a substantial following across YouTube and Instagram, where her videos regularly touch on everyday Indian life, relationships, body image, and health.
What makes her Mounjaro disclosure particularly impactful is her transparency. She didn’t post a polished transformation reel. She sat in front of a camera and walked her audience through months of nausea, hair loss, appetite changes, and doctor visits — and the why behind it all. She had been silently battling PCOS (Polycystic Ovary Syndrome), hypothyroidism, and clinical depression — a combination that makes conventional weight loss notoriously difficult.
Aishwarya Mohanraj’s Weight Loss Journey: A Timeline
Here is a structured, month-by-month overview of her documented Aishwarya Mohanraj Mounjaro weight loss progress, reconstructed from her public video:
| Timeline | Event / Milestone |
|---|---|
| Before May 2025 | Struggling with weight gain due to PCOS, hypothyroidism, and depression |
| May 1, 2025 | Started Mounjaro (tirzepatide) after consulting her doctor and reviewing blood reports |
| Week 1 | Lost approximately 1 kg |
| Month 1 | Lost approximately 4 kg total; experienced intense nausea |
| Months 2–3 | Appetite significantly reduced; nausea gradually subsided |
| Months 4–5 | Continued steady weight loss; hair fall became noticeable |
| Month 5–6 | Menstrual cycles became regular (linked to improved insulin resistance) |
| February 6, 2026 | Published YouTube video disclosing the full journey |
| End Result (6 months) | Weight declined from 74 kg → 52 kg (approximately 22 kg lost) |
The Key Weight Measurements: Before vs. After
This is where Sizematchr’s measurement focus really comes in. Let’s break down every significant number from her journey in both metric and imperial units.
Body Weight Comparison Table
| Measurement | Before (May 2025) | After (Nov 2025) | Change |
|---|---|---|---|
| Weight (Kilograms) | 74 kg | 52 kg | −22 kg |
| Weight (Pounds) | 163.1 lbs | 114.6 lbs | −48.5 lbs |
| Weight (Stones) | 11.65 st | 8.19 st | −3.46 st |
| Duration | — | — | 6 months (26 weeks) |
| Average loss per week | — | — | ~0.85 kg / ~1.87 lbs |
| Average loss per month | — | — | ~3.67 kg / ~8.08 lbs |
Sizematchr Note: To convert kilograms to pounds, multiply by 2.2046. To convert to stones, divide pounds by 14. Use our measurement converter for instant calculations.
BMI Estimation Table
BMI (Body Mass Index) is calculated as: weight (kg) ÷ height (m)²
Aishwarya’s exact height has not been publicly confirmed. Using an estimated height of 160 cm (5’3″) — common among South Indian women — here is how her BMI likely changed:
| Parameter | Before | After |
|---|---|---|
| Estimated Height | 160 cm / 5 ft 3 in | 160 cm / 5 ft 3 in |
| Weight | 74 kg | 52 kg |
| Estimated BMI | 28.9 (Overweight) | 20.3 (Healthy range) |
| BMI Category | Overweight | Normal |
| BMI Range | Classification |
|---|---|
| Below 18.5 | Underweight |
| 18.5 – 24.9 | Normal / Healthy Weight |
| 25.0 – 29.9 | Overweight |
| 30.0 – 34.9 | Obese (Class I) |
| 35.0 – 39.9 | Obese (Class II) |
| 40.0 and above | Severely Obese (Class III) |
Disclaimer: BMI is a general screening tool, not a diagnostic measure. It does not account for muscle mass, bone density, or distribution of fat.
What Is Mounjaro (Tirzepatide)? A Plain-English Explanation
Mounjaro is the brand name for tirzepatide, developed by pharmaceutical company Eli Lilly. It is a prescription injectable medication that works on two hormones simultaneously — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — which is why it’s called a dual incretin agonist.
In simpler terms: it mimics two natural gut hormones that your body releases after eating. This dual action:
- Reduces hunger by signaling your brain that you’re full
- Slows digestion so food stays in your stomach longer
- Improves insulin sensitivity, which is especially helpful for those with PCOS or Type 2 diabetes
- Reduces cravings — what many users describe as “food noise” going quiet
The drug was originally FDA-approved in May 2022 for Type 2 diabetes management. It received approval in India via DCGI (Drugs Controller General of India) and was officially launched by Eli Lilly in India in March 2025.
Mounjaro Dosage Schedule: From 2.5 mg to 15 mg
Mounjaro is a once-weekly injection administered subcutaneously (under the skin) in the stomach, thigh, or upper arm. Doctors typically start patients at the lowest dose and escalate gradually to minimize side effects.
Standard Dosage Escalation Chart
| Week Range | Dose | Notes |
|---|---|---|
| Weeks 1–4 | 2.5 mg | Starting dose — lowest, allows body to adjust |
| Weeks 5–8 | 5 mg | First dose increase after 4 weeks |
| Weeks 9–12 | 7.5 mg | Escalation if tolerated well |
| Weeks 13–16 | 10 mg | Mid-range therapeutic dose |
| Weeks 17–20 | 12.5 mg | Higher range |
| Week 21+ | 15 mg | Maximum approved dose |
Patients may stay at any dose level if they are achieving results and tolerating well. Escalation is NOT mandatory. Always follow your doctor’s individualized plan.
Injection Volume Reference
| Dose | Volume per Injection |
|---|---|
| 2.5 mg | 0.5 mL |
| 5 mg | 0.5 mL |
| 7.5 mg | 0.5 mL |
| 10 mg | 0.5 mL |
| 12.5 mg | 0.5 mL |
| 15 mg | 0.5 mL |
All doses come in a 0.5 mL pre-filled pen (KwikPen) or vial — the concentration changes, not the volume.
Mounjaro Cost in India (2026): What Does It Actually Cost?
This is one of the biggest questions after Aishwarya’s disclosure. She herself mentioned spending approximately ₹40,000 per month on injections — a figure that left many viewers stunned.
Here is the current pricing breakdown in India for 2026:
Mounjaro Vial Pricing (India)
| Dose | Price Per Vial (Weekly) | Estimated Monthly Cost (4 doses) |
|---|---|---|
| 2.5 mg | ₹3,281 – ₹3,500 | ₹13,125 – ₹14,000 |
| 5 mg | ₹4,101 – ₹4,375 | ₹16,404 – ₹17,500 |
Mounjaro KwikPen Pricing (India)
| Dose | Price Per KwikPen (Monthly Supply) |
|---|---|
| 2.5 mg | ₹13,125 |
| 5 mg | ₹16,406 |
| 7.5 mg | ~₹19,500 |
| 10 mg | ~₹22,000 |
| 12.5 mg | ~₹24,500 |
| 15 mg | ~₹25,781 |
Each KwikPen contains 4 doses — one month’s supply at once-weekly dosing.
USD Equivalent (Approximate)
| Monthly Dose | INR Cost | USD Equivalent (approx.) |
|---|---|---|
| 2.5 mg/week | ₹13,125 | ~$157 |
| 5 mg/week | ₹16,406 | ~$197 |
| 15 mg/week | ₹25,781 | ~$309 |
Note: In the US without insurance, Mounjaro can cost $1,000–$1,200/month. India’s pricing is significantly lower, though still inaccessible for most middle-income households.
Side Effects Aishwarya Experienced (And What Medicine Says)
Aishwarya did not hide the difficult parts of her Aishwarya Mohanraj Mounjaro weight loss journey. She openly discussed:
Side Effects She Reported
1. Intense Nausea (Month 1) The first month was the hardest. Nausea is the most commonly reported side effect of Mounjaro, particularly when starting or increasing doses. It typically improves as the body adjusts.
2. Significant Appetite Suppression Her appetite remained markedly reduced throughout. While this is the mechanism driving weight loss, it also means patients must consciously ensure adequate nutrition and protein intake.
3. Hair Loss (Telogen Effluvium) She noticed significant hair fall, which she associated with rapid weight loss. This is a recognized medical phenomenon called telogen effluvium — a temporary form of hair shedding triggered by sudden physical stress like rapid weight change. It typically reverses on its own within 3–6 months.
4. Menstrual Cycle Regulation Interestingly, her periods became regular after starting Mounjaro. She linked this to improved insulin resistance — a key driver of PCOS symptoms. This is a documented, positive side effect in women with PCOS.
Common Clinical Side Effects of Tirzepatide
| Side Effect | Frequency | Usually Resolves? |
|---|---|---|
| Nausea | Very common (>10%) | Yes, within weeks |
| Diarrhea | Common | Yes |
| Vomiting | Common | Yes |
| Constipation | Common | Yes |
| Abdominal pain | Common | Usually |
| Reduced appetite | Intended effect | Ongoing |
| Hair thinning | Possible (rapid loss) | Yes, typically |
| Headache | Occasional | Yes |
| Fatigue | Occasional | Yes |
Who Should NOT Use Mounjaro
Mounjaro is contraindicated (should not be used) in:
- People with a personal or family history of Medullary Thyroid Carcinoma (MTC)
- People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Those with hypersensitivity to tirzepatide
- Pregnant women or those planning to conceive (discontinue at least 1 month before intended pregnancy)
- Breastfeeding women
The PCOS + Hypothyroidism + Depression Factor
This section matters deeply for the millions of Indian women who saw themselves in Aishwarya’s story.
PCOS creates a cycle of insulin resistance that causes weight gain, which then worsens PCOS symptoms — making it nearly impossible to lose weight through diet and exercise alone for many women. Mounjaro’s GIP+GLP-1 dual mechanism directly addresses insulin resistance, which is why it can be particularly effective for PCOS patients.
Hypothyroidism slows your metabolism, making the body burn fewer calories at rest. Combined with PCOS, it creates what some doctors describe as a “double metabolic burden.”
Clinical depression disrupts motivation, sleep, and cortisol levels — all of which affect weight regulation. It also commonly leads to emotional eating patterns that are extremely difficult to break through willpower alone.
Aishwarya’s case is a reminder that obesity is often not a simple lifestyle problem but a complex medical condition influenced by hormones, mental health, and genetics. The fact that her periods normalized on Mounjaro — an unexpected benefit — illustrates how interconnected these systems are.
Mounjaro vs. Other Weight Loss Injections: A Comparison
Many readers ask how Mounjaro compares to Ozempic (semaglutide) and Wegovy, which are also popular GLP-1 drugs.
| Feature | Mounjaro (Tirzepatide) | Ozempic (Semaglutide) | Wegovy (Semaglutide) |
|---|---|---|---|
| Drug Type | Dual GIP + GLP-1 agonist | GLP-1 agonist | GLP-1 agonist |
| Dosing | Once weekly | Once weekly | Once weekly |
| Max Dose | 15 mg | 2 mg (diabetes) | 2.4 mg (obesity) |
| Avg. Weight Loss | ~20–22% of body weight | ~12–15% | ~15–17% |
| Approved for Obesity? | Yes (as Zepbound in US) | No (diabetes only) | Yes |
| Available in India? | Yes (March 2025) | Yes | Yes (June 2025) |
| Monthly Cost India | ₹13,125–₹25,781 | Lower | ₹10,850–₹16,400 |
| Hair loss risk | Yes (from rapid loss) | Yes (from rapid loss) | Yes (from rapid loss) |
Mounjaro generally shows greater weight loss results than semaglutide-based drugs in clinical trials, but individual results vary significantly.
Weight Loss Rate: Is 22 kg in 6 Months Safe?
A common concern after reading about Aishwarya Mohanraj’s Mounjaro weight loss story is whether losing 22 kg in six months is medically safe.
Weight Loss Rate Reference Table
| Rate of Loss | Category | Medical Opinion |
|---|---|---|
| 0.25–0.5 kg/week | Conservative | Considered very safe, sustainable |
| 0.5–1 kg/week | Moderate | Generally safe with medical supervision |
| 1–1.5 kg/week | Rapid | Acceptable short-term under medical guidance |
| >1.5 kg/week | Very Rapid | Requires close monitoring; risk of nutrient deficiency, hair loss, gallstones |
Aishwarya averaged approximately 0.85 kg per week — within the moderate-to-rapid range. This is why medical supervision is essential. Her doctors were monitoring her throughout.
What Doctors Say: The Medical Community’s Response
Following Aishwarya’s disclosure, several Indian doctors commented publicly. Dr. Manan Vora, an orthopaedic surgeon and health educator active on social media, explained the mechanism of the drug and emphasized that Mounjaro is a prescription medication requiring medical supervision — not a supplement you can self-administer.
The medical consensus is:
- Mounjaro can be appropriate for individuals with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities such as Type 2 diabetes, PCOS, or hypertension
- It is not a cosmetic drug for people who want to lose a few vanity kilograms
- Results are best when combined with dietary changes and increased physical activity
- Regular monitoring of blood parameters, thyroid function, and liver values is recommended
Aishwarya’s Advice to Her Followers
At the end of her video, Aishwarya’s message was clear and practical. She acknowledged the online judgment around medically assisted weight loss but stood firm:
“Just because something is easy doesn’t mean it’s wrong. Find reliable people, get help, and fix things however you can — because this is your only life.”
Her closing line was simply: “Consult a doctor.”
That’s advice worth repeating.
The Measurement Breakdown: Quick Reference Card
Because this is Sizematchr — and we believe every number should be clear and instantly useful — here is your full Aishwarya Mohanraj Mounjaro weight loss measurement card:
| What | Metric | Imperial |
|---|---|---|
| Starting weight | 74 kg | 163.1 lbs / 11.65 st |
| Final weight | 52 kg | 114.6 lbs / 8.19 st |
| Total weight lost | 22 kg | 48.5 lbs / 3.46 st |
| Journey duration | 6 months | ~26 weeks / ~182 days |
| Avg. weekly loss | 0.85 kg | 1.87 lbs |
| First week loss | ~1 kg | ~2.2 lbs |
| First month loss | ~4 kg | ~8.8 lbs |
| Estimated BMI before | 28.9 | Overweight |
| Estimated BMI after | 20.3 | Normal |
| Drug | Tirzepatide (Mounjaro) | — |
| Dose form | Weekly injection | 0.5 mL per dose |
Take a Look More this
Avneet Kaur Height in Feet 2026 – Measurements Guide, Comparison & Accurate Guide!
Shivam Dube Height in Feet 2026 – Impressive 6’4” Breakdown & Powerful Stats Revealed!!
Final Thoughts
The Aishwarya Mohanraj Mounjaro weight loss story resonated with so many people because it was honest. It didn’t erase the struggle — it documented it. She didn’t claim Mounjaro is for everyone. She said it worked for her, under medical supervision, after years of battling conditions that made conventional weight loss nearly impossible.
Frequently Asked Questions
Q: How much weight did Aishwarya Mohanraj lose on Mounjaro?
She lost approximately 22 kg (about 48.5 lbs) over six months, going from 74 kg to 52 kg.
Q: When did Aishwarya Mohanraj start Mounjaro?
She began on May 1, 2025, and disclosed her journey in a YouTube video released on February 6, 2026.
Q: How much does Mounjaro cost in India per month?
Costs range from approximately ₹13,125/month for the 2.5 mg dose to ₹25,781/month for the 15 mg dose (2026 pricing).
Q: Is Mounjaro approved in India?
Yes. The DCGI approved Mounjaro (tirzepatide) for Type 2 diabetes treatment in India. Eli Lilly officially launched it in India in March 2025. Approval for obesity (as Zepbound) is still under consideration.
Q: Can someone with PCOS use Mounjaro?
Mounjaro is not officially approved for PCOS treatment, but its mechanism addresses insulin resistance — a root cause of PCOS. Any use for PCOS must be under the guidance of an endocrinologist or gynecologist.
Q: Did Aishwarya Mohanraj keep the weight off?
Her video was released in February 2026 documenting her six-month journey ending in approximately November 2025. Long-term maintenance data for her personally is not publicly available.
Q: What was Aishwarya’s starting weight?
Her starting weight was 74 kg (approximately 163 lbs or 11.65 stone).
If you wanna more stardom related gossips then please visit sizescalematch.


